Urgent Information Regarding Drug RECALL – Department of Drug Administration
Samples of medicines collected during market monitoring from Department of Drug Administration are tested and manufactured by the manufacturers as per the specifications Batch no. The drug was found to be of low quality, Recall the sale and distribution as per Section 14 of the Drugs Act 2035 and withdraw it from the market immediately & This information has been published for the information of the official importers of the industry and their official representatives to submit the details to the Departmet of Drug Administration. Also, all concerned are requested not to recommend, sell, distribute and even use the drug.
Medicine:- BEN-A (Albendazole tablet USP) manufactured by ACME Laboratories.
For more Detail Visit :- Department of Drug Administration
- Department of Drug Administration-DDA
- Department of Drug Administration- DDA Important Information Regarding Recall of Medicine
- Department of Drug Administration Notice Regarding Misinformation of Covid-19
- Pharmacists in Government Health Services of Nepal
Pharma Info Nepal (Nabin’s Blog) is Popular Pharmacy information sharing online platform initiated by Nabin Bist since 2019. Thousands of Pharmacy professionals have trusted Pharma Info Nepal as a right blog to find the latest Pharma opportunities, information & resources for pharmacy updates in Nepal . If you have any complaints, information, or suggestions about the content published on Pharma Info Nepal/If you also like to write an article, please feel free to contact at firstname.lastname@example.org. Thanks for visiting us.
Nepal’s Leading Pharma Portal | Complete Pharma Updates